Cerus Stock Price - CERS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
After Hours
Last Trade
Last $ 3.99 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Cerus Corp CERS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.04 -0.99% 3.99 4.125 3.99 4.03 4.03 20:00:00
Bid Price Ask Price Spread Spread % News
3.00 4.50 1.50 33.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,844 840,152 $ 4.03 $ 3,384,838 933,728 3.70 - 6.88
Last Trade Time Type Quantity Stock Price Currency
16:00:11 formt 517 $ 3.99 USD

Cerus Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 566.93M 142.09M $ -57.56M -0.44 - 138.58M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 10.00 2.50%

more financials information »

Cerus News

Loading Messages....

Latest CERS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CERS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.144.143.703.94977,055-0.15-3.62%
1 Month4.374.533.704.16886,472-0.38-8.7%
3 Months5.315.36693.704.44910,222-1.32-24.86%
6 Months4.676.153.704.92862,086-0.68-14.56%
1 Year5.726.883.705.31851,461-1.73-30.24%
3 Years5.118.051.934.80951,034-1.12-21.92%
5 Years4.948.051.935.131,005,860-0.95-19.23%

Cerus Description

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: blood safety and generates revenue from the same.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.